Date published: 2026-5-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

MAML3 Inhibitors

MAML3 inhibitors belong to a specific class of chemical compounds designed to target and interact with the MAML3 protein. MAML3, which stands for Mastermind Like Transcriptional Coactivator 3, is a crucial protein involved in various cellular processes, particularly within the context of gene transcription and signaling pathways. Its primary role lies in acting as a transcriptional coactivator, facilitating the activation of specific genes by binding to various transcription factors, notably those belonging to the Notch signaling pathway. The Notch signaling pathway plays a pivotal role in controlling cell fate determination, differentiation, and development in multicellular organisms. Therefore, MAML3 inhibitors are designed to modulate this pathway by specifically blocking the function of MAML3.

The mechanism of action of MAML3 inhibitors typically involves interfering with the interaction between MAML3 and the transcription factors it coactivates. By disrupting this interaction, these inhibitors effectively impede the activation of target genes downstream of the Notch pathway, thereby influencing various cellular processes. The development and utilization of MAML3 inhibitors are driven by the need to understand and manipulate the Notch signaling pathway for research purposes, as well as to explore potential applications in areas such as cancer biology and developmental biology.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Inhibits tyrosine kinase activity in BCR-ABL, c-KIT, and PDGFR, studied in the research of leukemia.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Blocks the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) in cancer cells.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Targets multiple kinases, including Raf kinases and VEGFR, to inhibit angiogenesis and tumor growth.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

Selective inhibitor of Janus kinases (JAK1 and JAK2) for myeloproliferative disorders.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

Inhibits mTOR kinase, blocking cell proliferation and angiogenesis in various cancers.

MDV3100

915087-33-1sc-364354
sc-364354A
5 mg
50 mg
$245.00
$1051.00
7
(1)

Blocks the androgen receptor (AR) signaling pathway in prostate cancer.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

Selective inhibitor of BCL-2, promoting apoptosis in leukemia and lymphoma cells.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

Inhibits MEK1 and MEK2, interfering with the MAPK signaling pathway in cancer.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Irreversibly inhibits Bruton's tyrosine kinase (BTK) for B-cell malignancy.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

PARP inhibitor, disrupting DNA repair in cancer cells, especially in BRCA-mutated tumors.